Global Induced Pluripotent Stem Cells (iPSc) Market Research Report 2025(Status and Outlook)
Description
Report Overview
The market for Induced Pluripotent Stem Cells (iPSc) is driven by advancements in regenerative medicine, drug discovery, and disease modeling. iPSc technology, which involves reprogramming adult somatic cells into a pluripotent state, offers significant advantages over embryonic stem cells, including ethical acceptability and patient-specific applications. Key growth factors include increasing funding for stem cell research, rising prevalence of chronic diseases, and the demand for personalized medicine. Pharmaceutical and biotechnology companies are leveraging iPSc for toxicology screening and drug development, while academic and research institutions utilize them for studying disease mechanisms. Geographically, North America leads the market due to strong R&D investments and regulatory support, followed by Asia-Pacific, where Japan and China are emerging as hubs for iPSc research. However, high costs, technical complexities, and regulatory hurdles remain challenges. The competitive landscape features both established biotech firms and specialized startups, with collaborations and partnerships accelerating commercialization. As innovations in gene editing and 3D bioprinting expand iPSc applications, the market is projected to grow steadily, supported by increasing clinical trials and therapeutic potential.
The global Induced Pluripotent Stem Cells (iPSc) market size was estimated at USD 144.63 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 12.10% during the forecast period.
This report provides a deep insight into the global Induced Pluripotent Stem Cells (iPSc) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Induced Pluripotent Stem Cells (iPSc) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Induced Pluripotent Stem Cells (iPSc) market in any manner.
Global Induced Pluripotent Stem Cells (iPSc) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Lonza
Axol Bioscience Ltd.
Evotec
Hitachi Ltd.
Merck KGaA
REPROCELL Inc.
Fate Therapeutics
Thermo Fisher Scientific, Inc.
StemCellFactory III
Applied StemCell Inc.
Fujifilm Holding Corporation (CDI)
Ncardia
Sumitomo Dainippon harma
Astellas Pharma Inc
Pluricell Biotech
Cell Inspire Biotechnology
Market Segmentation (by Type)
Hepatocytes
Fibroblasts
Keratinocytes
Amniotic Cells
Market Segmentation (by Application)
Academic Research
Drug Development and Discovery
Toxicity Screening
Regenerative Medicine
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Induced Pluripotent Stem Cells (iPSc) Market
Overview of the regional outlook of the Induced Pluripotent Stem Cells (iPSc) Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Induced Pluripotent Stem Cells (iPSc) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Induced Pluripotent Stem Cells (iPSc), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
The market for Induced Pluripotent Stem Cells (iPSc) is driven by advancements in regenerative medicine, drug discovery, and disease modeling. iPSc technology, which involves reprogramming adult somatic cells into a pluripotent state, offers significant advantages over embryonic stem cells, including ethical acceptability and patient-specific applications. Key growth factors include increasing funding for stem cell research, rising prevalence of chronic diseases, and the demand for personalized medicine. Pharmaceutical and biotechnology companies are leveraging iPSc for toxicology screening and drug development, while academic and research institutions utilize them for studying disease mechanisms. Geographically, North America leads the market due to strong R&D investments and regulatory support, followed by Asia-Pacific, where Japan and China are emerging as hubs for iPSc research. However, high costs, technical complexities, and regulatory hurdles remain challenges. The competitive landscape features both established biotech firms and specialized startups, with collaborations and partnerships accelerating commercialization. As innovations in gene editing and 3D bioprinting expand iPSc applications, the market is projected to grow steadily, supported by increasing clinical trials and therapeutic potential.
The global Induced Pluripotent Stem Cells (iPSc) market size was estimated at USD 144.63 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 12.10% during the forecast period.
This report provides a deep insight into the global Induced Pluripotent Stem Cells (iPSc) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Induced Pluripotent Stem Cells (iPSc) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Induced Pluripotent Stem Cells (iPSc) market in any manner.
Global Induced Pluripotent Stem Cells (iPSc) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Lonza
Axol Bioscience Ltd.
Evotec
Hitachi Ltd.
Merck KGaA
REPROCELL Inc.
Fate Therapeutics
Thermo Fisher Scientific, Inc.
StemCellFactory III
Applied StemCell Inc.
Fujifilm Holding Corporation (CDI)
Ncardia
Sumitomo Dainippon harma
Astellas Pharma Inc
Pluricell Biotech
Cell Inspire Biotechnology
Market Segmentation (by Type)
Hepatocytes
Fibroblasts
Keratinocytes
Amniotic Cells
Market Segmentation (by Application)
Academic Research
Drug Development and Discovery
Toxicity Screening
Regenerative Medicine
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Induced Pluripotent Stem Cells (iPSc) Market
Overview of the regional outlook of the Induced Pluripotent Stem Cells (iPSc) Market:
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Induced Pluripotent Stem Cells (iPSc) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Induced Pluripotent Stem Cells (iPSc), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
Table of Contents
164 Pages
- 1 Research Methodology And Statistical Scope
- 1.1 Market Definition And Statistical Scope Of Induced Pluripotent Stem Cells (Ipsc)
- 1.2 Key Market Segments
- 1.2.1 Induced Pluripotent Stem Cells (Ipsc) Segment By Type
- 1.2.2 Induced Pluripotent Stem Cells (Ipsc) Segment By Application
- 1.3 Methodology & Sources Of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown And Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Induced Pluripotent Stem Cells (Ipsc) Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Induced Pluripotent Stem Cells (Ipsc) Market Size (M Usd) Estimates And Forecasts (2020-2033)
- 2.1.2 Global Induced Pluripotent Stem Cells (Ipsc) Sales Estimates And Forecasts (2020-2033)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size By Region
- 3 Induced Pluripotent Stem Cells (Ipsc) Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Induced Pluripotent Stem Cells (Ipsc) Product Life Cycle
- 3.3 Global Induced Pluripotent Stem Cells (Ipsc) Sales By Manufacturers (2020-2025)
- 3.4 Global Induced Pluripotent Stem Cells (Ipsc) Revenue Market Share By Manufacturers (2020-2025)
- 3.5 Induced Pluripotent Stem Cells (Ipsc) Market Share By Company Type (Tier 1, Tier 2, And Tier 3)
- 3.6 Global Induced Pluripotent Stem Cells (Ipsc) Average Price By Manufacturers (2020-2025)
- 3.7 Manufacturers’ Manufacturing Sites, Areas Served, And Product Types
- 3.8 Induced Pluripotent Stem Cells (Ipsc) Market Competitive Situation And Trends
- 3.8.1 Induced Pluripotent Stem Cells (Ipsc) Market Concentration Rate
- 3.8.2 Global 5 And 10 Largest Induced Pluripotent Stem Cells (Ipsc) Players Market Share By Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Induced Pluripotent Stem Cells (Ipsc) Industry Chain Analysis
- 4.1 Induced Pluripotent Stem Cells (Ipsc) Industry Chain Analysis
- 4.2 Market Overview Of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development And Dynamics Of Induced Pluripotent Stem Cells (Ipsc) Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 Pest Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Induced Pluripotent Stem Cells (Ipsc) Market Porter's Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy – April 2025
- 5.6.3 Global Trade Frictions And Their Impacts To Induced Pluripotent Stem Cells (Ipsc) Market
- 5.7 Esg Ratings Of Leading Companies
- 6 Induced Pluripotent Stem Cells (Ipsc) Market Segmentation By Type
- 6.1 Evaluation Matrix Of Segment Market Development Potential (Type)
- 6.2 Global Induced Pluripotent Stem Cells (Ipsc) Sales Market Share By Type (2020-2025)
- 6.3 Global Induced Pluripotent Stem Cells (Ipsc) Market Size Market Share By Type (2020-2025)
- 6.4 Global Induced Pluripotent Stem Cells (Ipsc) Price By Type (2020-2025)
- 7 Induced Pluripotent Stem Cells (Ipsc) Market Segmentation By Application
- 7.1 Evaluation Matrix Of Segment Market Development Potential (Application)
- 7.2 Global Induced Pluripotent Stem Cells (Ipsc) Market Sales By Application (2020-2025)
- 7.3 Global Induced Pluripotent Stem Cells (Ipsc) Market Size (M Usd) By Application (2020-2025)
- 7.4 Global Induced Pluripotent Stem Cells (Ipsc) Sales Growth Rate By Application (2020-2025)
- 8 Induced Pluripotent Stem Cells (Ipsc) Market Sales By Region
- 8.1 Global Induced Pluripotent Stem Cells (Ipsc) Sales By Region
- 8.1.1 Global Induced Pluripotent Stem Cells (Ipsc) Sales By Region
- 8.1.2 Global Induced Pluripotent Stem Cells (Ipsc) Sales Market Share By Region
- 8.2 Global Induced Pluripotent Stem Cells (Ipsc) Market Size By Region
- 8.2.1 Global Induced Pluripotent Stem Cells (Ipsc) Market Size By Region
- 8.2.2 Global Induced Pluripotent Stem Cells (Ipsc) Market Size Market Share By Region
- 8.3 North America
- 8.3.1 North America Induced Pluripotent Stem Cells (Ipsc) Sales By Country
- 8.3.2 North America Induced Pluripotent Stem Cells (Ipsc) Market Size By Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Induced Pluripotent Stem Cells (Ipsc) Sales By Country
- 8.4.2 Europe Induced Pluripotent Stem Cells (Ipsc) Market Size By Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Induced Pluripotent Stem Cells (Ipsc) Sales By Region
- 8.5.2 Asia Pacific Induced Pluripotent Stem Cells (Ipsc) Market Size By Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Induced Pluripotent Stem Cells (Ipsc) Sales By Country
- 8.6.2 South America Induced Pluripotent Stem Cells (Ipsc) Market Size By Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East And Africa
- 8.7.1 Middle East And Africa Induced Pluripotent Stem Cells (Ipsc) Sales By Region
- 8.7.2 Middle East And Africa Induced Pluripotent Stem Cells (Ipsc) Market Size By Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 Uae Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 9 Induced Pluripotent Stem Cells (Ipsc) Market Production By Region
- 9.1 Global Production Of Induced Pluripotent Stem Cells (Ipsc) By Region(2020-2025)
- 9.2 Global Induced Pluripotent Stem Cells (Ipsc) Revenue Market Share By Region (2020-2025)
- 9.3 Global Induced Pluripotent Stem Cells (Ipsc) Production, Revenue, Price And Gross Margin (2020-2025)
- 9.4 North America Induced Pluripotent Stem Cells (Ipsc) Production
- 9.4.1 North America Induced Pluripotent Stem Cells (Ipsc) Production Growth Rate (2020-2025)
- 9.4.2 North America Induced Pluripotent Stem Cells (Ipsc) Production, Revenue, Price And Gross Margin (2020-2025)
- 9.5 Europe Induced Pluripotent Stem Cells (Ipsc) Production
- 9.5.1 Europe Induced Pluripotent Stem Cells (Ipsc) Production Growth Rate (2020-2025)
- 9.5.2 Europe Induced Pluripotent Stem Cells (Ipsc) Production, Revenue, Price And Gross Margin (2020-2025)
- 9.6 Japan Induced Pluripotent Stem Cells (Ipsc) Production (2020-2025)
- 9.6.1 Japan Induced Pluripotent Stem Cells (Ipsc) Production Growth Rate (2020-2025)
- 9.6.2 Japan Induced Pluripotent Stem Cells (Ipsc) Production, Revenue, Price And Gross Margin (2020-2025)
- 9.7 China Induced Pluripotent Stem Cells (Ipsc) Production (2020-2025)
- 9.7.1 China Induced Pluripotent Stem Cells (Ipsc) Production Growth Rate (2020-2025)
- 9.7.2 China Induced Pluripotent Stem Cells (Ipsc) Production, Revenue, Price And Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Lonza
- 10.1.1 Lonza Basic Information
- 10.1.2 Lonza Induced Pluripotent Stem Cells (Ipsc) Product Overview
- 10.1.3 Lonza Induced Pluripotent Stem Cells (Ipsc) Product Market Performance
- 10.1.4 Lonza Business Overview
- 10.1.5 Lonza Swot Analysis
- 10.1.6 Lonza Recent Developments
- 10.2 Axol Bioscience Ltd.
- 10.2.1 Axol Bioscience Ltd. Basic Information
- 10.2.2 Axol Bioscience Ltd. Induced Pluripotent Stem Cells (Ipsc) Product Overview
- 10.2.3 Axol Bioscience Ltd. Induced Pluripotent Stem Cells (Ipsc) Product Market Performance
- 10.2.4 Axol Bioscience Ltd. Business Overview
- 10.2.5 Axol Bioscience Ltd. Swot Analysis
- 10.2.6 Axol Bioscience Ltd. Recent Developments
- 10.3 Evotec
- 10.3.1 Evotec Basic Information
- 10.3.2 Evotec Induced Pluripotent Stem Cells (Ipsc) Product Overview
- 10.3.3 Evotec Induced Pluripotent Stem Cells (Ipsc) Product Market Performance
- 10.3.4 Evotec Business Overview
- 10.3.5 Evotec Swot Analysis
- 10.3.6 Evotec Recent Developments
- 10.4 Hitachi Ltd.
- 10.4.1 Hitachi Ltd. Basic Information
- 10.4.2 Hitachi Ltd. Induced Pluripotent Stem Cells (Ipsc) Product Overview
- 10.4.3 Hitachi Ltd. Induced Pluripotent Stem Cells (Ipsc) Product Market Performance
- 10.4.4 Hitachi Ltd. Business Overview
- 10.4.5 Hitachi Ltd. Recent Developments
- 10.5 Merck Kgaa
- 10.5.1 Merck Kgaa Basic Information
- 10.5.2 Merck Kgaa Induced Pluripotent Stem Cells (Ipsc) Product Overview
- 10.5.3 Merck Kgaa Induced Pluripotent Stem Cells (Ipsc) Product Market Performance
- 10.5.4 Merck Kgaa Business Overview
- 10.5.5 Merck Kgaa Recent Developments
- 10.6 Reprocell Inc.
- 10.6.1 Reprocell Inc. Basic Information
- 10.6.2 Reprocell Inc. Induced Pluripotent Stem Cells (Ipsc) Product Overview
- 10.6.3 Reprocell Inc. Induced Pluripotent Stem Cells (Ipsc) Product Market Performance
- 10.6.4 Reprocell Inc. Business Overview
- 10.6.5 Reprocell Inc. Recent Developments
- 10.7 Fate Therapeutics
- 10.7.1 Fate Therapeutics Basic Information
- 10.7.2 Fate Therapeutics Induced Pluripotent Stem Cells (Ipsc) Product Overview
- 10.7.3 Fate Therapeutics Induced Pluripotent Stem Cells (Ipsc) Product Market Performance
- 10.7.4 Fate Therapeutics Business Overview
- 10.7.5 Fate Therapeutics Recent Developments
- 10.8 Thermo Fisher Scientific, Inc.
- 10.8.1 Thermo Fisher Scientific, Inc. Basic Information
- 10.8.2 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (Ipsc) Product Overview
- 10.8.3 Thermo Fisher Scientific, Inc. Induced Pluripotent Stem Cells (Ipsc) Product Market Performance
- 10.8.4 Thermo Fisher Scientific, Inc. Business Overview
- 10.8.5 Thermo Fisher Scientific, Inc. Recent Developments
- 10.9 Stemcellfactory Iii
- 10.9.1 Stemcellfactory Iii Basic Information
- 10.9.2 Stemcellfactory Iii Induced Pluripotent Stem Cells (Ipsc) Product Overview
- 10.9.3 Stemcellfactory Iii Induced Pluripotent Stem Cells (Ipsc) Product Market Performance
- 10.9.4 Stemcellfactory Iii Business Overview
- 10.9.5 Stemcellfactory Iii Recent Developments
- 10.10 Applied Stemcell Inc.
- 10.10.1 Applied Stemcell Inc. Basic Information
- 10.10.2 Applied Stemcell Inc. Induced Pluripotent Stem Cells (Ipsc) Product Overview
- 10.10.3 Applied Stemcell Inc. Induced Pluripotent Stem Cells (Ipsc) Product Market Performance
- 10.10.4 Applied Stemcell Inc. Business Overview
- 10.10.5 Applied Stemcell Inc. Recent Developments
- 10.11 Fujifilm Holding Corporation (Cdi)
- 10.11.1 Fujifilm Holding Corporation (Cdi) Basic Information
- 10.11.2 Fujifilm Holding Corporation (Cdi) Induced Pluripotent Stem Cells (Ipsc) Product Overview
- 10.11.3 Fujifilm Holding Corporation (Cdi) Induced Pluripotent Stem Cells (Ipsc) Product Market Performance
- 10.11.4 Fujifilm Holding Corporation (Cdi) Business Overview
- 10.11.5 Fujifilm Holding Corporation (Cdi) Recent Developments
- 10.12 Ncardia
- 10.12.1 Ncardia Basic Information
- 10.12.2 Ncardia Induced Pluripotent Stem Cells (Ipsc) Product Overview
- 10.12.3 Ncardia Induced Pluripotent Stem Cells (Ipsc) Product Market Performance
- 10.12.4 Ncardia Business Overview
- 10.12.5 Ncardia Recent Developments
- 10.13 Sumitomo Dainippon Harma
- 10.13.1 Sumitomo Dainippon Harma Basic Information
- 10.13.2 Sumitomo Dainippon Harma Induced Pluripotent Stem Cells (Ipsc) Product Overview
- 10.13.3 Sumitomo Dainippon Harma Induced Pluripotent Stem Cells (Ipsc) Product Market Performance
- 10.13.4 Sumitomo Dainippon Harma Business Overview
- 10.13.5 Sumitomo Dainippon Harma Recent Developments
- 10.14 Astellas Pharma Inc
- 10.14.1 Astellas Pharma Inc Basic Information
- 10.14.2 Astellas Pharma Inc Induced Pluripotent Stem Cells (Ipsc) Product Overview
- 10.14.3 Astellas Pharma Inc Induced Pluripotent Stem Cells (Ipsc) Product Market Performance
- 10.14.4 Astellas Pharma Inc Business Overview
- 10.14.5 Astellas Pharma Inc Recent Developments
- 10.15 Pluricell Biotech
- 10.15.1 Pluricell Biotech Basic Information
- 10.15.2 Pluricell Biotech Induced Pluripotent Stem Cells (Ipsc) Product Overview
- 10.15.3 Pluricell Biotech Induced Pluripotent Stem Cells (Ipsc) Product Market Performance
- 10.15.4 Pluricell Biotech Business Overview
- 10.15.5 Pluricell Biotech Recent Developments
- 10.16 Cell Inspire Biotechnology
- 10.16.1 Cell Inspire Biotechnology Basic Information
- 10.16.2 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (Ipsc) Product Overview
- 10.16.3 Cell Inspire Biotechnology Induced Pluripotent Stem Cells (Ipsc) Product Market Performance
- 10.16.4 Cell Inspire Biotechnology Business Overview
- 10.16.5 Cell Inspire Biotechnology Recent Developments
- 11 Induced Pluripotent Stem Cells (Ipsc) Market Forecast By Region
- 11.1 Global Induced Pluripotent Stem Cells (Ipsc) Market Size Forecast
- 11.2 Global Induced Pluripotent Stem Cells (Ipsc) Market Forecast By Region
- 11.2.1 North America Market Size Forecast By Country
- 11.2.2 Europe Induced Pluripotent Stem Cells (Ipsc) Market Size Forecast By Country
- 11.2.3 Asia Pacific Induced Pluripotent Stem Cells (Ipsc) Market Size Forecast By Region
- 11.2.4 South America Induced Pluripotent Stem Cells (Ipsc) Market Size Forecast By Country
- 11.2.5 Middle East And Africa Forecasted Sales Of Induced Pluripotent Stem Cells (Ipsc) By Country
- 12 Forecast Market By Type And By Application (2026-2033)
- 12.1 Global Induced Pluripotent Stem Cells (Ipsc) Market Forecast By Type (2026-2033)
- 12.1.1 Global Forecasted Sales Of Induced Pluripotent Stem Cells (Ipsc) By Type (2026-2033)
- 12.1.2 Global Induced Pluripotent Stem Cells (Ipsc) Market Size Forecast By Type (2026-2033)
- 12.1.3 Global Forecasted Price Of Induced Pluripotent Stem Cells (Ipsc) By Type (2026-2033)
- 12.2 Global Induced Pluripotent Stem Cells (Ipsc) Market Forecast By Application (2026-2033)
- 12.2.1 Global Induced Pluripotent Stem Cells (Ipsc) Sales (K Mt) Forecast By Application
- 12.2.2 Global Induced Pluripotent Stem Cells (Ipsc) Market Size (M Usd) Forecast By Application (2026-2033)
- 13 Conclusion And Key Findings
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
